Pediatrix Medical GroupFRA:PDC -0.94%57 Gross Margin % is 23.72% as of Mar. 2026, which is 10% below its 10-year median of 26.38. GuruFocus rates FRA:PDC with a GF Score™ of 57/100 and a GF Value™ of €11.17 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 631 Healthcare Providers & Services companies, Pediatrix Medical Group ranks worse than 73.38% on this metric.
FRA:PDC's Gross Margin % is ranked worse than 73.38% of 631
companies
in the Healthcare Providers & Services industry
Industry Median: 40.09
vs FRA:PDC: 26.09
Pediatrix Medical Group had a gross margin of 23.72% for the quarter that ended in Mar. 2026 => Competition eroding margins
The 5-Year average Growth Rate of Gross Margin for Pediatrix Medical Group was -1.90% per year.
Pediatrix Medical Group (FRA:PDC) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Pediatrix Medical Group had a gross margin of 23.72% for the quarter that ended in Mar. 2026 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Pediatrix Medical Group Gross Margin % Related Terms
Pediatrix Medical Group Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:PDC vs SGRY, ADUS, SNDA: Gross Margin % Comparison
For the Medical Care Facilities subindustry, Pediatrix Medical Group's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pediatrix Medical Group Gross Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Pediatrix Medical Group's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Pediatrix Medical Group's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Pediatrix Medical Group (FRA:PDC) has a Gross Margin % of 23.72% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Pediatrix Medical Group and its competitors. This is 10% below median its historical median of 26.38. Over the past decade, Pediatrix Medical Group's Gross Margin % has ranged from 21.13 to 32.47. According to the industry distribution chart, Pediatrix Medical Group ranks #463 out of 631 companies in the Healthcare Providers & Services industry, placing it in the top 73.4%.
Is Pediatrix Medical Group's Gross Margin % too high?
Pediatrix Medical Group's current Gross Margin % of 23.72% is 10% below median its 10-year median of 26.38. Over the past 10 years, this metric has ranged from a low of 21.13 to a high of 32.47. The Healthcare Providers & Services industry median Gross Margin % is 40.09. Pediatrix Medical Group's value of 23.72% is 40.8% below this industry median. Based on the distribution chart, Pediatrix Medical Group ranks #463 out of 631 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Pediatrix Medical Group has a GF Score™ of 57/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Pediatrix Medical Group's Gross Margin % compare to SGRY and ADUS?
According to the Healthcare Providers & Services industry distribution chart, Pediatrix Medical Group ranks #463 out of 631 companies for Gross Margin %. This places Pediatrix Medical Group in the lower half of its industry. The industry median Gross Margin % is 40.09. Pediatrix Medical Group's value of 23.72% is 40.8% below this benchmark. Historically, Pediatrix Medical Group's own Gross Margin % has ranged from 21.13 to 32.47 over the past decade. While the company's 10-year median is 26.38 vs. the industry median of 40.09, Pediatrix Medical Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Healthcare Providers & Services company?
The median Gross Margin % among Healthcare Providers & Services companies is 40.09, based on 631 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pediatrix Medical Group's current Gross Margin % of 23.72% is 40.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Pediatrix Medical Group and its competitors. For the Healthcare Providers & Services industry, the median Gross Margin % is 40.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pediatrix Medical Group's current Gross Margin % is 23.72%, which is 10% below median its own 10-year median of 26.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pediatrix Medical Group stock overvalued right now?
Based on GuruFocus' analysis, Pediatrix Medical Group (FRA:PDC) is currently considered Significantly Overvalued. The stock's GF Value™ is €11.17, compared to a current price of €21.00 — trading 88% above its estimated fair value. The current Gross Margin % is 23.72%, which is 10% below median its 10-year median of 26.38 and 40.8% below the Healthcare Providers & Services industry median of 40.09. Pediatrix Medical Group's overall GF Score™ is 57/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Pediatrix Medical Group (FRA:PDC), the current Gross Margin % is 23.72% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pediatrix Medical Group (FRA:PDC) Overvalued in 2026?
Based on GuruFocus' analysis, Pediatrix Medical Group stock appears to be overvalued.
The current stock price of €21.00 is trading 88% above its estimated GF Value™ of €11.17.
GuruFocus considers Pediatrix Medical Group to be Significantly Overvalued.
Key valuation signals for FRA:PDC:
Gross Margin %: 23.72% (10% below median its 10-year median of 26.38)
GF Value™: €11.17 vs. price of €21.00 (88% above fair value)
Industry Position: 40.8% below the Healthcare Providers & Services median (#463 of 631)
No single metric tells the full story. See the FRA:PDC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.
57GF Score
Get the complete analysis for FRA:PDC
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:PDC has been successfully added to your 
